A brief review of cardiovascular diseases, associated risk factors and current treatment regimes

GD Flora, MK Nayak - Current pharmaceutical design, 2019 - ingentaconnect.com
Cardiovascular diseases (CVDs) are the leading cause of premature death and disability in
humans and their incidence is on the rise globally. Given their substantial contribution …

Perioperative management of aneurysmal subarachnoid hemorrhage: a narrative review

D Sharma - Anesthesiology, 2020 - pubs.asahq.org
Aneurysmal subarachnoid hemorrhage is an acute neurologic emergency. Prompt definitive
treatment of the aneurysm by craniotomy and clipping or endovascular intervention with …

Prophylactic therapies for morbidity and mortality after aneurysmal subarachnoid hemorrhage: a systematic review and network meta-analysis of randomized trials

M Dayyani, B Sadeghirad, JC Grotta, S Zabihyan… - Stroke, 2022 - Am Heart Assoc
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high
mortality and morbidity. We aimed to determine the relative benefits of pharmacological …

[HTML][HTML] The mechanism and relevant mediators associated with neuronal apoptosis and potential therapeutic targets in subarachnoid hemorrhage

Q Tian, S Liu, SM Han, W Zhang, XY Qin… - Neural regeneration …, 2023 - journals.lww.com
Subarachnoid hemorrhage (SAH) is a dominant cause of death and disability worldwide. A
sharp increase in intracranial pressure after SAH leads to a reduction in cerebral perfusion …

[HTML][HTML] Role of damage associated molecular pattern molecules (DAMPs) in aneurysmal subarachnoid hemorrhage (aSAH)

SR Chaudhry, A Hafez, B Rezai Jahromi… - International journal of …, 2018 - mdpi.com
Aneurysmal subarachnoid hemorrhage (aSAH) represents only a small portion of all strokes,
but accounts for almost half of the deaths caused by stroke worldwide. Neurosurgical …

[HTML][HTML] Inflammation and anti-inflammatory targets after aneurysmal subarachnoid hemorrhage

S Muhammad, D Hänggi - International journal of molecular sciences, 2021 - mdpi.com
Aneurysmal subarachnoid hemorrhage (aSAH), with a crude worldwide incidence of around
7.9 per 100,000 person-years [1] and accounting for only 5% of all strokes, is a potentially …

[HTML][HTML] Cerebral pressure autoregulation in brain injury and disorders–a review on monitoring, management, and future directions

TS Wettervik, M Fahlström, P Enblad, A Lewén - World neurosurgery, 2022 - Elsevier
The role of cerebral pressure autoregulation (CPA) in brain injury and disorders has gained
increased interest. The CPA is often disturbed as a consequence of acute brain injury, which …

[HTML][HTML] Aneurysmal subarachnoid hemorrhage: strategies for preventing vasospasm in the intensive care unit

MN Diringer, AR Zazulia - Seminars in respiratory and critical …, 2017 - thieme-connect.com
This article addresses the intensive care unit (ICU) management of patients with aneurysmal
subarachnoid hemorrhage (SAH), with an emphasis on the prevention of cerebral …

Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review

R Jabbarli, D Pierscianek, M Darkwah Oppong… - Neurosurgical …, 2020 - Springer
Delayed cerebral ischemia (DCI) is a severe complication of subarachnoid hemorrhage
(SAH). Clinical and radiographic features of SAH may be helpful in identification of …

Clinical value of inflammatory cytokines in patients with aneurysmal subarachnoid hemorrhage

C Luo, J Yao, H Bi, Z Li, J Li, G Xue, K Li… - … Interventions in Aging, 2022 - Taylor & Francis
Background Inflammation is closely associated with prognosis in patients with aneurysmal
subarachnoid hemorrhage (aSAH), which is orchestrated by inflammatory cytokines …